The Welsh chapter of the Royal Pharmaceutical Society, along with ten other royal colleges and professional bodies, have renewed calls for the urgent
transformation of mental health services to address increasing demands on the NHS in Wales.
Representatives of the Royal College Mental Health Expert Advisory Group joined members of the Senedd in Cardiff to outline the work of the group over the past
year and to explain why a well-trained, fully supported and equipped multi-disciplinary workforce is critical for the development of care for people with mental
health conditions.
To make sustainable change happen, the group is calling for a greater focus by the Welsh government and NHS Wales on the following:
The critical changes needed to improve the delivery and structure of mental health services across Wales in community, hospital and specialist secure settings.
Parity of access to mental health services for the most vulnerable patients, ensuring they have equal access opportunities that vulnerable patients would receive for
physical health conditions.
The Pharmacists' Defence Association has called on the Scottish government to end unnecessary pharmacy closures and introduce emergency regulations to force
companies that operate Scotland's pharmacies to open on the days and hours they have agreed.
It is concerned that decisions made by some health boards in Scotland have now allowed pharmacy owners to close their pharmacies on Saturdays.
The PDA is worried that a pharmacy closure could have negative impact on patients and other parts of the NHS, including neighbouring pharmacies, addiction and mental
health services, and minor injury and A&E units.
The association claims that there are record numbers of registered pharmacists who are available to work and therefore a decision to close a pharmacy over staff
shortages is misleading.
"The business owners may claim there is a shortage of pharmacists, but when they actively cancel agreed hours of work it does not suggest there is a shortfall of
workers," said the PDA, adding: "These business decisions often include closing their pharmacies at very short notice, even when pharmacists are available and willing
to work."
Whether it's the effects of the coronavirus pandemic and those suffering with long Covid, or the financial pressures of rising living costs, these hard times
can affect absolutely anyone's mental health.
Mental health problems have worsened across all age-groups in the last few years, from lack of social interaction, unexpected bereavements or the significant impact
of a physical injury or long-term illness taking its toll on mental wellbeing - these challenging experiences and situations that we face throughout life leave a
big strain on the population.
Ultimately, there is an urgent need to reduce rising levels of mental ill-health in our society. As a pharmacist with 25 years' experience in healthcare, I feel I
have an obligation to my patients to support them with their healthcare needs, and mental health should be treated just the same as physical health.
Despite efforts to improve NHS mental health services, patients may still not be receiving the appropriate immediate care as they are often provided with online
counselling or an App for long-term support (online support introduced since the pandemic).
Community pharmacists are in a unique position to be advocates for patients with mental illness as they are the healthcare professionals' patients see most often.
This is a good opportunity for pharmacists to speak to patients face-to-face and give them advice in a more practical way rather than potentially waiting weeks for
an GP appointment.
The International Pharmaceutical Federation (FIP) has published two new handbooks to support pharmacists in providing 'much-needed' mental health services.
The federation unveiled "Mental healthcare - A handbook for pharmacists" and "Knowledge and skills reference guide for professional development in mental health
care" on Thursday July 7.
The handbooks, developed in collaboration with an international group of experts, aim to support pharmacy practice, presenting the many potential mental health
care actions that pharmacists can perform, from preventing mental illness and screening for signs to optimising medication and responding to mental health crises.
The reference guide is intended to accompany the handbook and defines the knowledge and skills that pharmacists need to acquire to provide such services.
Pharmacy professionals to be included as key stakeholders in the implementation, delivery and evaluation of a wide range of genomic services, said the Royal
Pharmaceutical Society (RPS).
RPS's statement has been developed in collaboration with pharmacy organisations who have co-badged the report, such as the British Oncology Pharmacy Association,
the UK Clinical Pharmacy Association, Association of Pharmacy Technicians and the College of Mental Health Pharmacy.
It looks at current and future roles for pharmacy professionals in genomic medicine across many aspects of practice such as person-centred care and collaboration,
professional practice, education, leadership, management and research.
Pharmacists and pharmacy technicians in the UK have already established roles in the application of genomic medicine in some areas of practice, such as antimicrobial
stewardship and infectious diseases, and the management of certain genetic conditions, such as cystic fibrosis.
The society believes, the current role of pharmacy professionals in genomics can be expanded upon in the future to both lead and support many relevant aspects of
genomic implementation. These are described across all healthcare sectors, within the Genome UK strategy produced by the UK Government, and within the implementation
plans published in England, Scotland and Wales.
Lead for Pharmacogenomics at RPS Sophie Harding said: "Pharmacy professionals are the gatekeepers of medication safety and efficacy across all areas of healthcare.
They are skilled at interpreting complex scientific data and use evidence-based medicine to maximise the benefits of treatments for patients, whilst supporting
shared decision-making with patients and the multidisciplinary team.
As part of its centenary celebrations, the National Pharmacy Association (NPA) has raised more than eleven thousand pounds for mental health charity Mind.
A total of £11,583 was raised for Mind and the Association continues to encourage members to support the charity.
The NPA marked its 100th birthday in 2021 and partnered with Mind in England and Wales, and equivalent charities in Scotland and Northern Ireland - SAMH (Scottish Association for Mental Health) and Inspire Wellbeing - to raise awareness of pharmacy services for people with mental health problems and to generate funds for the work of these charities.
The NPA held set-piece events, such as sponsored walks, and pharmacists, colleagues and their families and friends were encouraged to organise their own activities.
Chief executive of the NPA, Mark Lyonette, said: "I was delighted to be at our sponsored walk in St Albans, home of our head office, last year. This and other fundraising events all underlined the message that community pharmacies are concerned with the wellbeing of the whole person - mind as well as body."
In its latest style guide for digital health writing, the NHS advises bloggers and writers to avoid using the word 'chemist' when referring to a 'pharmacy' as users are more likely to look for the latter.
Likewise, the content guide titled 'A to Z of NHS health writing' encourages writers to use 'ethnic minorities' rather than the more commonly used abbreviated forms
such as 'BAME' or 'BME'.
"Use a capital letter when you're writing about ethnicity or when you're asking users for their ethnic group," it advises, and therefore recommends writing 'Black,
Asian, African, Black British or Caribbean' or 'people from a White British background'.
In a further chapter on 'Ethnicity, Religion and Nationality,' it notes that a writer should "only refer to people's ethnic heritage or religion if it's relevant to the content."
Likewise, when talking about skin colour, the style guide asks to use terms that are easy to understand including brown and black skin. "We do not refer to brown or black skin as 'dark' or 'darker'."
It advises not to describe people as mentally ill but use phrases such as 'mental health condition' or 'mental health problems'.
In a bid to bolster the educational experience for undergraduate pharmacy students across London, Kingston University has embarked on a groundbreaking
project in collaboration with University College London and King's College London.
This initiative, fueled by a substantial £1.5 million investment from National Health Services England (NHSE), aims to elevate the quality and consistency of
pharmacy placements throughout the capital for new pharmacy entrants.
The project is designed to address the evolving standards set forth by the General Pharmaceutical Council (GphC), ensuring that newly-trained pharmacists
are well-prepared to meet the demands of their profession.
By standardizing and expanding pharmacy placements, the three universities seek to provide students with a comprehensive and diverse range of "experiential
learning opportunities".
More pharmacies should do NHS Health Checks to improve access, a new study that focuses on ways to improve the lives of people living with obesity, recommends.
The report, Levelling Up Obesity Care, by pharma giant Novo Nordisk follows a series of roundtables with patient advocates, healthcare professionals and academics to generate understanding on the future of obesity care in England.
Amongst its recommendations, the report says that 'to widen access and alleviate pressure on GP services, consideration should be given to expanding NHS Health
Checks in community pharmacy'.
NHS Health Checks include a measurement of Body Mass Index (BMI).
Those most likely to benefit from a Health Check include people who live in more deprived areas, and are more likely to be living with obesity, says the report.
Boots UK to offer a free health MOT for over 40s in England between 1st April until 30th June to help eligible patients identify and take the right steps to
address high blood pressure and the potential for increased risk of other health conditions.
The Free Health MOT will give over 40s the information needed for them to take actions to support their overall health. It consists of a 15-minute appointment with
a Boots pharmacist, during which they will receive- the NHS Blood Pressure Check Service, with GP referral if needed; optional BMI (Body Mass Index) and waist
circumference measurement; lifestyle guidance on exercise, nutrition, sleep, mental wellbeing and stopping smoking; and personalised advice and recommendations .
At the end of their appointment, patients will receive a booklet containing information about how to lead a healthy lifestyle and a section with the results of their
MOT recorded.
Claire Nevinson, Superintendent Pharmacist at Boots, said: "The Free Health MOT at Boots is intended to help people gain greater insight into their health and take
the steps they need to improve it. As we get older, we become more vulnerable to conditions like high blood pressure, so it's important that we take steps to help
stay healthy. The checks done during the MOT and the advice provided not only helps individual patients lead healthier lives but also reduces pressure on the NHS by
offering accessible care in pharmacies at the heart of communities."
The availability of appointments for a Free Health MOT at Boots comes at a time when new research indicates people want to lead healthier lives.
In a significant uptick reflecting growing awareness and acceptance of mental health challenges among new and expectant mothers, NHS records reveal a
striking surge in specialist support sought by over 57,000 new mothers over the past year.
This figure represents a substantial 33 per cent increase compared to the 2022 data findings indicating a heightened demand for perinatal mental health services
in England.
Last year, the number of women accessing perinatal mental health services was 43,053 individuals.
Specifically, between March 2023 and February 2024, a total of 57,170 women accessed these services, representing a significant rise from the 43,053 women who received support between March 2022 and February 2023.
Contextually, this surge in demand is significant given that approximately 600,000 women give birth in England each year.
The Integrated Care Systems (ICSs) provide an opportunity to break the silo mentality in the health and care sector, National Pharmacy Association (NPA) chair
Andrew Lane told MPs.
While giving evidence to the Health and Social Care Select Committee on 6 December about the effectiveness of ICSs, Lane also poured cold water on newspaper reports
that community pharmacists will be drafted in to break the NHS strike, as he reiterated the call for a "properly costed and funded environment."
"We've been in different silos historically and ICSs are an opportunity to pull all systems together for the benefit of patients," he told committee members.
Lane pointed to dementia-trained pharmacy delivery drivers and the Discharge Medicines Service as instances where the influence of community pharmacy already
stretches beyond primary care into hospitals and social care.
"We've seen pharmacists prescribe and get UTIs off doctors' desks, so we are starting to release capacity [in the system] and we're on that clinical journey.
We welcome that, but it has to be with the right level of funding," he added.
Too many unreasonable demands placed on pharmacists by employers affect their health and wellbeing at work, a stress and wellbeing survey conducted by The Pharmacists' Defence Association (PDA) Union revealed.
The survey, conducted during Autumn 2021, covered views of over 2,000 pharmacists employed by big multiples - Lloyds, Boots, and Well.
This survey used questions developed by the Health and Safety Executive (HSE), which enabled the union to understand more about stress and wellbeing in three of the
largest community pharmacy multiples.
Analysing the survey, the PDA said that some pharmacists working for each of the three employers highlighted "unachievable targets, unrealistic time pressures, and
most worrying of all reported numerous instances of bullying and harassment."
An overwhelming majority of the respondents reflected personal sacrifices made by the pharmacists to ensure patient services are not impacted by the poor conditions
and environments in some pharmacies.
Workforce issues, staff retention and capacity continues to be a big concern for the Local Pharmaceutical Committee as it discussed the topics at a recent meeting with the Pharmaceutical Services Negotiating Committee (PSNC).
The meeting, attended by delegates from 66 LPCs, focused on the current challenges faced by community pharmacies as well as the planning for the next year.
Around 64 per cent of delegates said workforce was the top challenge faced by pharmacy contractors, and suggested reducing the migration of pharmacists to Primary Care Networks (PCNs).
Other suggestions included - "improving the development opportunities available for pharmacists and their teams, and rebranding the profession to make community pharmacy a more attractive route for young graduates."
On the development of Integrated Care Systems (ICS), the majority of respondents were positive about their LPC's engagement in the new setting.
The Professional Pharmacists Association (PDA) has demanded efforts to secure greater support and recognition for community pharmacists from governmental
bodies.
In its written evidence provided to the Health and Social Care select committee's pharmacy inquiry, the PDA raised concerns about the well-being of pharmacists,
specifically for those who belong to minority ethnic groups and race and are subjected to bullying, harassment, and ill-treatment.
The association highlighted issues in the workplace that impact pharmacists' health and well-being, including chronic understaffing, sub-standard working
environments, an absence of protected training time, and experiences of racism, violence, and abuse.
Parallel to the PDA's advocacy, the Royal Pharmaceutical Society (RPS) is intensifying calls for prioritising workforce wellbeing within the pharmacy domain.
Stressing the pivotal role of workforce retention in addressing current challenges, RPS emphasises the need for robust support mechanisms and equitable access
to mental health services.
Poverty not only takes a significant toll on people's health but also leads to additional costs for the National Health Service (NHS). Rise in deep poverty,
cost-of-living crisis, and high pressure on NHS services have worsened the situation, according to a study published by The King's Fund this week.
The report underscored that poverty and deprivation contribute to a greater prevalence of diseases, difficulties in accessing health care, late or delayed
treatment, and worse health outcomes. These challenges could be seen across various NHS services, spanning from emergency care to dental services
Additionally, it revealed that 30 per cent of people living in the most deprived areas have turned to 999, 111, A&E or a walk-in centre because they could not
access a GP appointment.
In 2016, the Joseph Rowntree Foundation (JRF) estimated the cost of poverty on health care at £29 billion (£34 billion in current prices). As the proportion of
people living in deep poverty has risen, the situation has worsened. In 2021/22, six million people were living in very deep poverty, up from 4.5 million two
decades ago. Currently, more than one in five people in the UK are estimated to be living in poverty, the report noted.
Deprivation is linked to a range of diet-related health problems, including cardiovascular disease and diabetes, as well as mental illness. According to the
report, the depression rate is two times higher among people living in the most deprived areas, compared to the least deprived areas.
The Royal Pharmaceutical Society (RPS) has released findings from its fifth annual workforce wellbeing survey, which was conducted in collaboration with the
profession's charity, Pharmacist Support.
Exposing the mental health challenges faced by pharmacists, the survey revealed a troubling statistic: 86 per cent of pharmacists are at a high risk of burnout.
Inadequate staffing was the main factor contributing to burnout, followed by lack of work-life balance, insufficient protected learning time, absence of colleague
or senior support, and long working hours.
While pharmacies are encouraged to provide more clinical services, more than 60 per cent of pharmacists surveyed reported that they were not being offered
"sufficient protected learning time" to focus on their professional development and learning needs.
The survey also exposed a distressing trend of workplace abuse, with over 40 per cent of pharmacists reporting verbal abuse from the public, and 25 per cent
from colleagues or managers.
A final review of gender services provided by the NHS has uncovered significant shortcomings, leaving thousands of vulnerable children questioning their
gender identity without adequate support.
The report, led by Dr. Hilary Cass, a prominent consultant paediatrician, highlights the use of unproven treatments and the detrimental impact of the polarized
trans debate on gender care provision.
The investigation, commissioned by NHS England in 2020, focused on the Tavistock and Portman NHS mental health trust's gender identity development services (Gids),
which treated around 9,000 children and young people between 2009 and 2020.
Shockingly, the review found that despite limited evidence of effectiveness and potential health risks, puberty blockers and cross-sex hormones were routinely
administered.
Dr. Cass emphasized that the "rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or
psychosocial health. The effect on cognitive and psychosexual development remains unknown."
A new Attention-Deficit-Hyperactive disorder (ADHD) taskforce has been launched by National Health Services England (NHSE) to counter the challenges faced
by many suffering from the neurodevelopmental condition.
The ADHD taskforce aligns with the NHS Long Term Plan's vision to revolutionise mental health services, with a specific emphasis on bolstering community-based
care and reducing reliance on inpatient services.
The NHS has partnered with the government to tackle the escalating demands including increasing funding, improving system efficiency, altering the service
provision model, and clinical prioritisation by bringing together expertise from across a broad range of sectors, including the NHS, education and justice,
to help provide a joined-up approach in response to concerns around rising demand.
Over the past two decades, there has been a significant expansion in the acknowledgement and successful medical interventions for ADHD, leading to a steady
rise in clinical requests throughout the UK.
The Royal Pharmaceutical Society (RPS) has called on employers, governments and NHS organisations to provide pharmacists with regular protected learning
time (PLT) within working hours to develop their skills in clinical delivery, education, research and leadership.
RPS workforce wellbeing survey showed an average 42 per cent of pharmacists were not given any PLT, a figure which rose to 55 per cent in community pharmacy. Most
were unable to engage in professional development activities as part of their working day because of their responsibility to deliver frontline clinical services to
patients.
This means learning is often undertaken outside of working hours, increasing pressure on individuals and impacting their work/life balance.
The survey showed that 48 per cent of respondents identified a lack of PLT as negatively affecting their mental health and wellbeing and that 88 per cent were at
high risk of burnout.
PLT improves the quality of patient care through professional practice and reflection, helping to develop insights, maintain and refine care standards and increase
confidence. It facilitates continuous professional development (CPD), ensuring that skills and knowledge are up to date.